From diagnostic tools to clinical trial enrichment and surrogate endpoint markers, biomarkers are important tools that have the potential to reduce the length, cost, and uncertainty of drug development. A[…]
Tagged: clinical trial
More
Orphan Drugs & Diseases
In the 1960s, the United States congress passed the “Drug Efficacy Amendment”, which introduced for the first time a requirement for pharmaceutical companies to disclose side effects and dangers of[…]